PhD Scholarship in Extracellular Vesicle Biomarkers for Precision Medicine Safety and Efficacy

Description

Flinders University is offering a prestigious PhD scholarship for an outstanding candidate to join a leading translational research program investigating extracellular vesicle (EV)–derived biomarkers as tools to predict medicine safety, therapeutic response, and treatment efficacy.

This project sits at the intersection of molecular medicine, clinical pharmacology, and precision health, and aims to develop non-invasive, highly sensitive EV-based assays that can transform how clinicians monitor and tailor therapy. The successful candidate will work within a collaborative, multidisciplinary environment including experts in EV biology, advanced omics, oncology, clinical trials, and computational analysis.

This is an exceptional opportunity for a motivated researcher to contribute to cutting-edge science with real-world clinical impact, build a strong publication track record, and gain experience with state-of-the-art technologies.

The successful candidate will join a vibrant research community at Flinders University with access to modern laboratory facilities, advanced analytical instrumentation, and a supportive supervisory team committed to career development. The project offers a unique chance to contribute to a rapidly evolving field with high translational potential, potentially shaping how next-generation therapies are monitored and personalised.

Candidates with curiosity, resilience, and passion for scientific discovery are strongly encouraged to apply.

Benefits

Full-time PhD scholarship for 3 years, with a possible 6-month extension.

• Tax-free stipend aligned with competitive RTP rates; higher allowance may be available for exceptional applicants.
• Additional top-up funding may be available for high-performing candidates.

Access to specialised training in:

• Extracellular vesicle isolation and characterisation
• Nanoscale analytics and multi-omics
• Clinical trial sample processing
• Bioinformatics and AI-driven clinical biomarker translation 

Opportunities for:

• Conference travel and research dissemination
• Industry, hospital, and national research collaborations

Eligibility

Essential

• A completed Honours degree (Class I or equivalent) or Master’s degree with significant research component in biomedical science, biochemistry, molecular biology, clinical sciences, pharmacology, or a related discipline.
• Strong written and verbal communication skills.
• Evidence of research capability (e.g., publications, thesis excellence, presentations, or competitive grades).
• Ability to work both independently and collaboratively in a research team.
• Demonstrated interest in precision medicine, biomarker development, oncology, or pharmacology.
• Commitment to translational research with clinical impact.

Eligibility

• Domestic (Australian/NZ) applicants are welcome.
• Applicants must meet Flinders University PhD entry requirements and be eligible for enrollment full-time.